|
| << previous | next >> |
Journal description
All volumes of the corresponding journal
All issues of the corresponding volume
All articles of the corresponding issues
Details for article 16 of 43 found articles
| Title: |
First-line venetoclax combinations versus chemoimmunotherapy in fit patients with chronic lymphocytic leukaemia (GAIA/CLL13): 4-year follow-up from a multicentre, open-label, randomised, phase 3 trial |
| Author: |
Fürstenau, Moritz Kater, Arnon P Robrecht, Sandra von Tresckow, Julia Zhang, Can Gregor, Michael Thornton, Patrick Staber, Philipp B Tadmor, Tamar Lindström, Vesa Juliusson, Gunnar Janssens, Ann Levin, Mark-David da Cunha-Bang, Caspar Schneider, Christof Goldschmidt, Neta Vandenberghe, Elisabeth Rossi, Davide Benz, Rudolf Nösslinger, Thomas Heintel, Daniel Poulsen, Christian B Christiansen, Ilse Frederiksen, Henrik Enggaard, Lisbeth Posthuma, Eduardus F M Issa, Djamila E Visser, Hein P J Bellido, Mar Kutsch, Nadine Dürig, Jan Stehle, Alexander Vöhringer, Matthias Böttcher, Sebastian Schulte, Clemens Simon, Florian Fink, Anna-Maria Fischer, Kirsten Holmes, Emily E Kreuzer, Karl-Anton Ritgen, Matthias Brüggemann, Monika Tausch, Eugen Stilgenbauer, Stephan Hallek, Michael Niemann, Carsten U Eichhorst, Barbara |
| Appeared in: |
Lancet oncology |
| Paging: | Volume 25 () nr. 6 pages 744-759 |
| Year: |
2024 |
| Contents: | |
| Publisher: |
The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license |
| Source file: |
Elektronische Wetenschappelijke Tijdschriften |
Details for article 16 of 43 found articles
| << previous | next >> |